FI20050212A0 - Modified triggering dosage form - Google Patents

Modified triggering dosage form

Info

Publication number
FI20050212A0
FI20050212A0 FI20050212A FI20050212A FI20050212A0 FI 20050212 A0 FI20050212 A0 FI 20050212A0 FI 20050212 A FI20050212 A FI 20050212A FI 20050212 A FI20050212 A FI 20050212A FI 20050212 A0 FI20050212 A0 FI 20050212A0
Authority
FI
Finland
Prior art keywords
dosage form
modified triggering
triggering
modified
dosage
Prior art date
Application number
FI20050212A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Kari Vahervuo
Marja Partanen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20050212A priority Critical patent/FI20050212A0/en
Publication of FI20050212A0 publication Critical patent/FI20050212A0/en

Links

FI20050212A 2005-02-23 2005-02-23 Modified triggering dosage form FI20050212A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI20050212A FI20050212A0 (en) 2005-02-23 2005-02-23 Modified triggering dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20050212A FI20050212A0 (en) 2005-02-23 2005-02-23 Modified triggering dosage form

Publications (1)

Publication Number Publication Date
FI20050212A0 true FI20050212A0 (en) 2005-02-23

Family

ID=34224241

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20050212A FI20050212A0 (en) 2005-02-23 2005-02-23 Modified triggering dosage form

Country Status (1)

Country Link
FI (1) FI20050212A0 (en)

Similar Documents

Publication Publication Date Title
NL301259I2 (en) Gadopiclenol
NL300966I1 (en) caplacizumab
RU2398586C3 (en) PHARMACEUTICAL COMPOSITION
BRPI0616703A2 (en) pharmaceutical dosage form
CY2014030I1 (en) THERAPEUTIC COMPOSITIONS INCLUDING INGENOL-3-ANGELATE
DK1986650T3 (en) MANIPULATION-SAFE DOSAGE FORMS
DK1940467T3 (en) Long-release drug composition
DE602006007875D1 (en) CAPSULES
DK1957073T3 (en) PHARMACEUTICAL
BRPI0511900A (en) pharmaceutical compositions
DK2343071T3 (en) Pharmaceutical dosage forms
DE602006012066D1 (en) THEREOF
DE602006013636D1 (en) DOSE COUNTER
ATE453384T1 (en) NEW DOSAGE FORMULATION
DE602006020744D1 (en) SYRINGE
DK1757293T3 (en) BH4-RESPONSIVE HYPERPHENYLALANINARY MEDICINES
DE602006005688D1 (en) INJECTED STOREY
DE112005003670A5 (en) event arrangement
NO20052035D0 (en) Stop Mass
DE502005005839D1 (en) FELDGEERÄT
BRPI0614413A2 (en) compound and pharmaceutical composition
BRPI0614412A2 (en) compound and pharmaceutical composition
DE602006001436D1 (en) crusher
ITMI20041447A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING GABAPENTINA
DE502006002564D1 (en) inventions

Legal Events

Date Code Title Description
FD Application lapsed